Cynthia Collins Derm Tech, Inc. (DMTK) insider trading activity

DMTK Quotes by TradingView

Cynthia Collins is Director of DermTech, Inc.. Currently has a direct ownership of 104,835 shares of DMTK, which is worth approximately $4,193. The most recent transaction as insider was on Jun 01, 2023, when has been sold 35,714 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
0% 3M change
0% 12M change
Total Value Held $4,193

Cynthia Collins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2023
BUY
Grant, award, or other acquisition
-
35,714 Added 25.41%
104,835 Common Stock
May 26 2022
BUY
Grant, award, or other acquisition
-
26,480 Added 27.7%
69,121 Common Stock
May 26 2021
BUY
Grant, award, or other acquisition
-
9,158 Added 17.68%
42,641 Common Stock

Also insider at

EDIT
Editas Medicine, Inc. Healthcare
CEO
PSTX
Poseida Therapeutics, Inc. Healthcare
CERT
Certara, Inc. Healthcare
MXCT
MAXCYTE, INC. Healthcare
CC

Cynthia Collins

Director
Princeton, NJ

Track Institutional and Insider Activities on DMTK

Follow DermTech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMTK shares.

Notify only if

Insider Trading

Get notified when an Derm Tech, Inc. insider buys or sells DMTK shares.

Notify only if

News

Receive news related to DermTech, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DMTK